Our investigation demonstrated that treatment of A549 with the NEU1 inhibitor D-PAC slightly inhibited the clone-forming ability of tumor cells, and that combination with sotorasib did not affect the antitumor activity of sotorasib further supports the above hypothesis. This evidence concerns the gene NEU1 and neoplasm.